Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Promethazine Recall Issued After Hypertension Pill Found in Bottle June 9, 2014 Russell Maas Add Your Comments About 10,200 bottles of allergy pills are being removed from stores shelves after a report suggests that some bottles may contain blood pressure pills, which could pose a serious risk for consumers and potentially cause adverse health consequences for consumers with allergies.  Zydus Pharmaceuticals issued a promethazine recall on May 28, indicating that a 25 milligram (mg) high blood pressure pill was found in a bottle of the allergy medication. To date, no injuries or severe adverse health reactions have been reported. The recalled promethazine hydrochloride tablets are used to treat seasonal allergies, skin irritations, food or inhalant allergens, and for control of nausea and vomiting after receiving certain types of anesthesia and surgery. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In an FDA notification letter, the agency was informed of a report where a consumer found a 25 mg atenolol pill in the allergy pills bottle. Atenolol is used to treat hypertension. The manufacturer’s action has been categorized by the FDA as a Class II recall, indicating the presence of the atenolol in the blood pressure medication may cause temporary or medically reversible adverse health consequences. The recalled allergy pills were manufactured by Zydus Pharmaceuticals USA Inc., of Pennington, New Jersey and were sold nationwide. The recalled pill bottles are labeled with Lot number MN9081 and have an expiration date of September 2015. The pill mix-up came just a little over two months after a similar incident led to a massive Effexor recall. In March, the massive pharmaceutical manufacturer Pfizer had to recall roughly 104,450 bottles of antidepressant Effexor XR and the generic version Venlafaxine after a customer found the heart drug Tikosyn in the antidepressant bottle. The FDA mandated the recall after announcing the accidental ingestion of both the antidepressants and the heart drug could cause fatal reactions. Tags: Atenolol, Effexor, Hypertension, Promethazine, Zydus Pharmaceuticals More Lawsuit Stories Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker March 19, 2025 AngioDynamics Lawsuit Claims Xcela Port Catheter Caused Acute Embolism March 19, 2025 Amazon Challenges Responsibility To Notify Customers About Recalled Products March 19, 2025 2 Comments mekita January 6, 2016 Is there a lawsuit for Atenolol? Gary February 9, 2016 Is there a lawsuit for Atenolol? I know that since I have been taking it I have had all the side effects of this medication but one. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (Posted: today) A federal judge has appointed the BioZorb lawyers to serve in various leadership positions during coordinated pretrial proceedings in the rapidly growing litigation, taking actions that benefit all plaintiffs pursuing a claim against Hologic. MORE ABOUT: BIOZORB LAWSUITBreast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025) Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (Posted: yesterday) A federal judge is expediting Depo-Provera brain tumor lawsuits towards resolution by permitting direct filing of new claims with the MDL court and appointing numerous plaintiffs’ attorneys to leadership roles. MORE ABOUT: DEPO-PROVERA LAWSUIT75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (03/03/2025) Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (Posted: 2 days ago) The U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITSuboxone Lawyers Report on Status of Lawsuits Over Tooth Decay, Dental Damage (03/11/2025)Medical Records of Suboxone Tooth Decay Must Be Produced Under MDL Court Order (02/20/2025)Lawyers in Suboxone Dental Lawsuits Fail To Reach Agreement on Bellwether Selection Process (02/06/2025)
Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker March 19, 2025
Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (Posted: today) A federal judge has appointed the BioZorb lawyers to serve in various leadership positions during coordinated pretrial proceedings in the rapidly growing litigation, taking actions that benefit all plaintiffs pursuing a claim against Hologic. MORE ABOUT: BIOZORB LAWSUITBreast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)
Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (Posted: yesterday) A federal judge is expediting Depo-Provera brain tumor lawsuits towards resolution by permitting direct filing of new claims with the MDL court and appointing numerous plaintiffs’ attorneys to leadership roles. MORE ABOUT: DEPO-PROVERA LAWSUIT75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (03/03/2025)
Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (Posted: 2 days ago) The U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITSuboxone Lawyers Report on Status of Lawsuits Over Tooth Decay, Dental Damage (03/11/2025)Medical Records of Suboxone Tooth Decay Must Be Produced Under MDL Court Order (02/20/2025)Lawyers in Suboxone Dental Lawsuits Fail To Reach Agreement on Bellwether Selection Process (02/06/2025)